Network pharmacology of iridoid glycosides from Eucommia ulmoides Oliver against osteoporosis

Abstract

Eucommia ulmoides Oliver is one of the commonly used traditional Chinese medicines for the treatment of osteoporosis, and iridoid glycosides are considered to be its active ingredients against osteoporosis. This study aims to clarify the chemical components and molecular mechanism of iridoid glycosides of Eucommia ulmoides Oliver in the treatment of osteoporosis by integrating network pharmacology and molecular simulations. The active iridoid glycosides and their potential targets were retrieved from text mining as well as Swiss Target Prediction, TargetNet database, and STITCH databases. At the same time, DisGeNET, GeneCards, and Therapeutic Target Database were used to search for the targets associated with osteoporosis. A protein–protein interaction network was built to analyze the interactions between targets. Then, DAVID bioinformatics resources and R 3.6.3 project were used to carry out Gene Ontology enrichment analysis and Kyoto Encyclopedia of Genes and Genomes pathway analysis. Moreover, interactions between active compounds and potential targets were investigated through molecular docking, molecular dynamic simulation, and binding free energy analysis. The results showed that a total of 12 iridoid glycosides were identified as the active iridoid glycosides of Eucommia ulmoides Oliver in the treatment of osteoporosis. Among them, aucubin, reptoside, geniposide and ajugoside were the core compounds. The enrichment analysis suggested iridoid glycosides of Eucommia ulmoides Oliver prevented osteoporosis mainly through PI3K-Akt signaling pathway, MAPK signaling pathway and Estrogen signaling pathway. Molecular docking results indicated that the 12 iridoid glycosides had good binding ability with 25 hub target proteins, which played a critical role in the treatment of osteoporosis. Molecular dynamic and molecular mechanics Poisson–Boltzmann surface area results revealed these compounds showed stable binding to the active sites of the target proteins during the simulations. In conclusion, our research demonstrated that iridoid glycosides of Eucommia ulmoides Oliver in the treatment of osteoporosis involved a multi-component, multi-target and multi-pathway mechanism, which provided new suggestions and theoretical support for treating osteoporosis.

Network pharmacology and in silico approaches to uncover multitargeted mechanism of action of Zingiber zerumbet rhizomes for the treatment of idiopathic pulmonary fibrosis

“…The overlapped gene symbols, referred to as targets of zingiber zerumbet in IPF were then obtained by uploading the component gene and the disease gene using the Venny 2.1 (https://bioinfogp.cnb.csic.es/tools/ venny) duplication method mapping tool. 37…”

“…The Compound-Target-Pathway network was built by merging the Compound-Target and Pathway-Target networks in order to better understand the interactions among the phytomolecules, targets, and pathways. 37 Based on the pathway analysis, the top 20 key pathways were considered with the enriched hub targets to build and analyse the pathway-target network. The relationship between the primarily screened compounds with their top subnetwork targets was developed and analysed.…”

Mechanisms by which kidney-tonifying Chinese herbs inhibit osteoclastogenesis: Emphasis on immune cells

“…It was found that ethanol extracts from Eucommiae Cortex alleviated the inflammatory response through the OPG/RANK/RANKL and NF-κB pathways to delay the destruction of intraarticular cartilage and bone. Zhang et al (2021) ; Wang et al (2022a) ; Zhang et al (2014) The ethanol extracts and polysaccharides from Eucommiae Cortex increased the coefficient of the thymus and spleen and improved the clearance ability and phagocytosis ability of peritoneal Mφs in mice. Qiu et al (2008) ; Ye et al (2015) Osthole may restore BMSC-mediated T-cell migration and apoptosis by stimulating the expression of Fas/FasL, enhancing the immune activity of BMSCs in healthy or inflammatory microenvironments to treat OP ( Yu et al 2021 ), and downregulating c-Scr, β3-integrin and OC genes to inhibit OC formation and bone resorption.…”

Geniposide alleviates cholesterol-induced endoplasmic reticulum stress and apoptosis in osteoblasts by mediating the GLP-1R/ABCA1 pathway

“…GEN becomes a research agent in preclinical studies related with diseases [ 20 ]. GEN has been shown to improve osteoporosis [ 21 ]. ATP-binding cassette transporter A1 (ABCA1) is a carrier for the intracellular cholesterol out of the cytoplasm [ 22 ].…”